Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
Even the panel of “odor specialists” resisted the urge to cover their noses as pungent smells emanated from the smelliest sneakers in this year’s Annual National Odor-Eaters Rotten Sneaker Contest. Ready to be judged, seven kids, ages seven to sixteen, from across the country have arrived in Montpelier today, selected as national finalists, wearing the decrepit and odorous rubber-soles that won them regional recognition.
In its 37th year, the National Odor-Eaters Rotten Sneaker Contest is the ultimate test of just how dirty and stinky sneakers can get when they’re part of an active kid’s life, going where they go, through puddles, mud and all. Sneakers are judged on the conditions of the sole, tongue, heel, toe, laces or velcro, eyelets/grommets, overall condition and most important ODOR, by a panel that includes NASA “Master Sniffer” George Aldrich, Chemical Specialist for NASA space missions, and Rachel Herz, Ph.D., a professor at Brown University and author of The Scent of Desire and That’s Disgusting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55027-37-th-annual-odor-eaters-rotten-sneaker-contest
http://iwillbuyyourhome.com We buy houses St. Louis! There are many reasons why a home owner would want to sell a house fast. Job change, relocation, debt problems, divorce and inheritance are just a few. If you are thinking how can I sell my house and would like to receive a free, confidential, no-obligation home selling offer, simply give us a call or complete our on-line seller form and our local home buying and selling expert will be in contact with you shortly. We help people with great credit, good credit, little or no credit, bad credit, prior bankruptcy, foreclosure, divorce, whatever. We buy in any area, in any condition for any reason!
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the launch of the Simply Smart Rewards Program for Clear + Brilliant laser treatments, the first-ever patient loyalty program in aesthetic laser skin resurfacing.
Clear + Brilliant and Clear + Brilliant Perméa treatments have been shown to help improve skin tone, texture and other subtle signs of aging. The precise laser energy has allowed most consumers to experience immediate and progressive results that last for months, but vary by age, skin condition and how they protect their skin. The treatment takes about 20 minutes, is safe for all skin types and is suitable for men and women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61178-solta-medical-launches-clear-brilliant-simply-smart-rewards-program
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
